Higher Risk, Higher Reward? Self-Reported Effects of Real-World Cannabis Use in Parkinson's Disease.

ABSTRACT:

Background

Despite limited evidence, people with Parkinson's disease (PD) use cannabis for therapeutic purposes. Given barriers to performing randomized trials, exploring real-world experiences with cannabis in PD is valuable.

Objective

Investigate the frequency and magnitude of symptomatic effects reported with cannabis use in PD.

Methods

An anonymous, 15-question, web-based survey was deployed on Fox Insight. Cannabis product types were defined (by relative tetrahydrocannabinol [THC] and cannabidiol [CBD] content) and respondents were asked to reference product labels. Questions focused on use patterns and subjective effects on 36 predefined symptoms (rated -2-markedly worse to +2-markedly better).

Results

1,881 people with PD responded (58.5% men; mean age 6

SUBMITTER: Holden SK 

PROVIDER: S-EPMC8974868 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature